According to Altimmune's latest financial reports the company's total debt is $0.67 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $1.12 M | -26.78% |
2021-12-31 | $1.53 M | -15.88% |
2020-12-31 | $1.82 M | 4.63% |
2019-12-31 | $1.74 M | 204.51% |
2018-12-31 | $0.57 M | -11.83% |
2017-12-31 | $0.64 M | -34.02% |
2016-12-31 | $0.98 M | |
2014-12-31 | $0.74 M | -73.56% |
2013-12-31 | $2.82 M | -25.43% |
2012-12-31 | $3.78 M | |
2010-12-31 | $N/A | -100% |
2009-12-31 | $17.42 M | -4.8% |
2008-12-31 | $18.3 M | -11.43% |
2007-12-31 | $20.66 M | 75.63% |
2006-12-31 | $11.76 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.32 B | 48,568.26% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | N/A | N/A | ๐บ๐ธ USA |